Related Experiment Video
Updated: Aug 2, 2026

12:34
Collection, Isolation, and Flow Cytometric Analysis of Human Endocervical Samples
Published on: July 6, 2014
Abnormal cervical screen follow-up among low-income Latinas: Project SAFe
Kathleen Ell1, Betsy Vourlekis, Laila Muderspach
1School of Social Work, University of Southern California, MRF 214 (MC 0411), Los Angeles, CA 90089-0411, USA.
Journal of Women'S Health & Gender-Based Medicine
|October 25, 2002
Summary
The Screening Adherence Follow-Up Program (SAFe) improved follow-up adherence for low-income women with abnormal Pap tests. This case management program demonstrated high satisfaction and may enhance cervical cancer screening follow-up.
Area of Science:
- Public Health
- Gynecologic Oncology
- Health Services Research
Background:
- Cervical cancer disproportionately affects low-income women, linked to poor follow-up after Pap tests.
- Barriers to adherence include personal, systemic, and psychosocial factors.
- The Screening Adherence Follow-Up Program (SAFe) was developed to address these barriers.
Purpose of the Study:
- To pilot the SAFe program, an individualized case management intervention.
- To assess the impact of SAFe on follow-up adherence after abnormal Pap results.
- To evaluate patient satisfaction with the SAFe program.
Main Methods:
- A pilot study involving 196 low-income women with low-grade (LGSIL) or high-grade (HGSIL) squamous intraepithelial lesions.
- SAFe utilized a clinical decision-making algorithm for tailored interventions: health education, counseling, and systems navigation.
- Adherence rates were compared between SAFe participants and a non-enrolled comparison group.
Main Results:
- Initial adherence post-intervention was 83% for LGSIL and 93% for HGSIL.
- Over one year, full adherence was 41% (LGSIL) and 61% (HGSIL); partial adherence was 42% (LGSIL) and 32% (HGSIL).
- SAFe participants showed comparable or improved adherence to non-enrollees (58% LGSIL, 67% HGSIL) and reported 93% satisfaction.
Conclusions:
- SAFe effectively addressed psychosocial and system barriers to adherence through a multidisciplinary team.
- The program demonstrated high acceptability and potential to improve medical care management for at-risk women.
- SAFe may enhance follow-up adherence for women with abnormal cervical screening results.

